Indian Army Pharmaceutical Supplies Procurement for Medications and Nasal Treatments

Work Description - NA

This tender, identified by Bid Number GEM/2026/B/7930074, is being issued by the Department of Military Affairs, under the Ministry of Defence, for the Indian Army, with the bidding closing on September 1st, 2026, at 1:00 PM. The procurement encompasses a comprehensive range of pharmaceutical supplies, with a total quantity of 15,230 units, specifically including critical medications such as Syrup Terbutaline Sulphate (1 and 25 mg) combined with Bromhexine HCl (4 mg) and Guaifenesin (50 mg) per 5 ml bottle of 100 ml; Haematinic Capsules containing Ferrous Fumarate with 100mg elemental Iron and Folic Acid 500 mcg; Tranexamic Acid in both 500 mg per 5ml injectable form and 500 mg tablet form; Isosorbide Mononitrate 20 mg tablets; Torsemide 10 mg scored tablets; Adenosine 3 mg per 2 ml injection; Ramipril in 2 and 5 mg tablet strengths; Metoprolol XL 25 mg tablets; Dopamine HCl 40 mg per 5 ml injection; Telmisartan 40 mg tablets; Amlodipine Besylate 5 mg tablets; and a combination tablet of Telmisartan 40 mg, Amlodipine 10 mg, and Hydrochlorothiazide 12.5 mg, as well as Sodium Chloride 0.65% w/v Nasal Drops in 15 ml bottles and Nasal Decongestant Tablets. The tender is being managed by the office located in KUPWARA.